Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trials

Two once-daily inhaled bronchodilators, indacaterol and tiotropium, are widely used as first-line therapy in stable COPD patients. This study was performed to compare the clinical efficacy and safety between indacaterol and tiotropium in patients with moderate-to-severe COPD. MEDLINE, EMBASE, and Co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2015-03, Vol.10 (3), p.e0119948-e0119948
Hauptverfasser:	Kim, Jung Soo, Park, Jinkyeong, Lim, Seong Yong, Oh, Yeon-Mok, Yoo, Kwang Ha, Park, Yong Bum, Sheen, Seung Soo, Kim, Min-Ji, Carriere, K C, Jung, Ji Ye, Park, Hye Yun
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-2 Receptor Agonists - therapeutic use Bias Bronchodilator Agents - therapeutic use Bronchodilators Care and treatment Chronic obstructive lung disease Chronic obstructive pulmonary disease Clinical trials Collaboration Comparative analysis Cough Critical care Effectiveness Forced Expiratory Volume - drug effects Handbooks Hospitals Humans Indans - therapeutic use Internal medicine Medicine Meta-analysis Patients Pulmonary Disease, Chronic Obstructive - drug therapy Quality of life Quinolones - therapeutic use Randomization Randomized Controlled Trials as Topic Respiratory system agents Rhinopharyngitis Safety Studies Systematic review Tiotropium Bromide - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!